215 related articles for article (PubMed ID: 28251920)
1. Nonpainful remote electrical stimulation alleviates episodic migraine pain.
Yarnitsky D; Volokh L; Ironi A; Weller B; Shor M; Shifrin A; Granovsky Y
Neurology; 2017 Mar; 88(13):1250-1255. PubMed ID: 28251920
[TBL] [Abstract][Full Text] [Related]
2. Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.
Yarnitsky D; Dodick DW; Grosberg BM; Burstein R; Ironi A; Harris D; Lin T; Silberstein SD
Headache; 2019 Sep; 59(8):1240-1252. PubMed ID: 31074005
[TBL] [Abstract][Full Text] [Related]
3. Remote electrical neuromodulation (REN) in the acute treatment of migraine: a comparison with usual care and acute migraine medications.
Rapoport AM; Bonner JH; Lin T; Harris D; Gruper Y; Ironi A; Cowan RP
J Headache Pain; 2019 Jul; 20(1):83. PubMed ID: 31331265
[TBL] [Abstract][Full Text] [Related]
4. Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial.
Martelletti P; Barbanti P; Grazzi L; Pierangeli G; Rainero I; Geppetti P; Ambrosini A; Sarchielli P; Tassorelli C; Liebler E; de Tommaso M;
J Headache Pain; 2018 Nov; 19(1):101. PubMed ID: 30382909
[TBL] [Abstract][Full Text] [Related]
5. Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial.
Chou DE; Shnayderman Yugrakh M; Winegarner D; Rowe V; Kuruvilla D; Schoenen J
Cephalalgia; 2019 Jan; 39(1):3-14. PubMed ID: 30449151
[TBL] [Abstract][Full Text] [Related]
6. Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study.
Tassorelli C; Grazzi L; de Tommaso M; Pierangeli G; Martelletti P; Rainero I; Dorlas S; Geppetti P; Ambrosini A; Sarchielli P; Liebler E; Barbanti P;
Neurology; 2018 Jul; 91(4):e364-e373. PubMed ID: 29907608
[TBL] [Abstract][Full Text] [Related]
7. Sumatriptan-naproxen and butalbital: a double-blind, placebo-controlled crossover study.
Derosier F; Sheftell F; Silberstein S; Cady R; Ruoff G; Krishen A; Peykamian M
Headache; 2012 Apr; 52(4):530-43. PubMed ID: 22103635
[TBL] [Abstract][Full Text] [Related]
8. Remote electrical neuromodulation for acute treatment of migraine in adolescents.
Hershey AD; Lin T; Gruper Y; Harris D; Ironi A; Berk T; Szperka CL; Berenson F
Headache; 2021 Feb; 61(2):310-317. PubMed ID: 33349920
[TBL] [Abstract][Full Text] [Related]
9. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
[TBL] [Abstract][Full Text] [Related]
10. Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial.
Grazzi L; Tassorelli C; de Tommaso M; Pierangeli G; Martelletti P; Rainero I; Geppetti P; Ambrosini A; Sarchielli P; Liebler E; Barbanti P;
J Headache Pain; 2018 Oct; 19(1):98. PubMed ID: 30340460
[TBL] [Abstract][Full Text] [Related]
11. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L
CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study).
Cady RK; McAllister PJ; Spierings EL; Messina J; Carothers J; Djupesland PG; Mahmoud RA
Headache; 2015 Jan; 55(1):88-100. PubMed ID: 25355310
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, placebo-controlled, crossover study of early-intervention with sumatriptan 85/naproxen sodium 500 in (truly) episodic migraine: what's neck pain got to do with it?
Calhoun AH; Ford S
Postgrad Med; 2014 Mar; 126(2):86-90. PubMed ID: 24685971
[TBL] [Abstract][Full Text] [Related]
14. Acute Treatments for Episodic Migraine in Adults: A Systematic Review and Meta-analysis.
VanderPluym JH; Halker Singh RB; Urtecho M; Morrow AS; Nayfeh T; Torres Roldan VD; Farah MH; Hasan B; Saadi S; Shah S; Abd-Rabu R; Daraz L; Prokop LJ; Murad MH; Wang Z
JAMA; 2021 Jun; 325(23):2357-2369. PubMed ID: 34128998
[TBL] [Abstract][Full Text] [Related]
15. A Randomized Trial of Ketorolac vs. Sumatripan vs. Placebo Nasal Spray (KSPN) for Acute Migraine.
Rao AS; Gelaye B; Kurth T; Dash PD; Nitchie H; Peterlin BL
Headache; 2016 Feb; 56(2):331-40. PubMed ID: 26840902
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of 2-Hour Post-Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult-to-Treat Migraine Attacks.
Tepper SJ; Vasudeva R; Krege JH; Rathmann SS; Doty E; Vargas BB; Magis D; Komori M
Headache; 2020 Sep; 60(8):1601-1615. PubMed ID: 32634275
[TBL] [Abstract][Full Text] [Related]
17. Evaluating Mean Level and Within-Person Consistency in Migraine Pain Intensity and Migraine-Related Disability for AVP-825 vs Oral Sumatriptan: Results from the COMPASS Study, A Randomized Trial.
McGinley JS; Buse DC; Shulman KJ; Wirth RJ; Hugentobler E; Lipton RB
Headache; 2019 Jul; 59(7):1002-1013. PubMed ID: 31062349
[TBL] [Abstract][Full Text] [Related]
18. Migraine prevention with percutaneous mastoid electrical stimulator: A randomized double-blind controlled trial.
Juan Y; Shu O; Jinhe L; Na Y; Yushuang D; Weiwei D; Lanying H; Jian W
Cephalalgia; 2017 Nov; 37(13):1248-1256. PubMed ID: 27821639
[TBL] [Abstract][Full Text] [Related]
19. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J
Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016
[TBL] [Abstract][Full Text] [Related]
20. DFN-02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double-Blind, Placebo-Controlled Study.
Lipton RB; Munjal S; Brand-Schieber E; Rapoport AM
Headache; 2018 May; 58(5):676-687. PubMed ID: 29878341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
